Doctor Jeffrey Michel
Baylor Scott and White Health, Austin (United States of America)
Time to event analysis in patients managed on rivaroxaban while taking concurrent interacting medications (CIM)
Event: ESC Congress 2018
Topic: Anticoagulants
Session: Antiplatelet and anticoagulant drugs
Increased bleeding events in patients co-administered rivaroxaban and either cyp3A4 or p-gp inhibitors
Event: ESC Congress 2017
Topic: Pharmacology
Session: How to make oral anticoagulation safe
ESC 365 is supported by
